This suggests that PI3K pathway inactivation abolishes the anti-neuroblastoma effect of the HDAC8 inhibitor, exemplarily shown for knockdown of PIK3CA, PIK3CB, PIK3R1 and PIK3R4 in Fig. 1f, g. The gene discussed is HDAC8; the disease is neuroblastoma.